This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (118)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Venous Thromboembolism  • Surgery  • Blood/ Coagulation  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

A Systematic Review

Andrew S. Dunn, MD; Alexander G. G. Turpie, MD, FRCP

Arch Intern Med. 2003;163:901-908.

Background  The safety and efficacy of various management strategies for patients receiving oral anticoagulants (OACs) who need to undergo surgery or invasive procedures are unknown.

Methods  We performed a systematic review and synthesis of the English-language literature examining the perioperative management and outcomes of patients receiving long-term OAC therapy.

Results  Thirty-one reports were identified. The quality of the identified reports was generally poor; no randomized controlled trials have been performed and duration of follow-up was typically not stated. Overall, 29 thromboembolic events occurred amont 1868 patients (1.6%; 95% confidence interval, 1.0%-2.1%), including 7 strokes (0.4%; 95% confidence interval, 0%-0.7%). Thromboembolic event rates by management strategy were 0.4% (1 of 237) for continuation of OAC, 0.6% (6 of 996) for discontinuation of OAC therapy without administration of intravenous heparin, 0% (0 of 166) for discontinuation of OAC therapy with administration of intravenous heparin, 0.6% (1 of 180) for discontinuation of OAC therapy with administration of low-molecular-weight heparin, and 8.0% (21 of 263) for unspecified or unclear strategies. Major bleeding while receiving therapeutic OAC was rare for dental procedures (0.2% [4 of 2014]), arthrocentesis (0% [0 of 32]), cataract surgery (0% [0 of 203]), and upper endoscopy or colonoscopy with or without biopsy (0% [0 of 111]).

Conclusions  Most patients can undergo dental procedures, arthrocentesis, cataract surgery, and diagnostic endoscopy without alteration of their regimen. For other invasive and surgical procedures, oral anticoagulation needs to be withheld, and the decision whether to pursue an aggressive strategy of perioperative administration of intravenous heparin or subcutaneous low-molecular-weight heparin should be individualized. The current literature is substantially limited in its ability to help choose an optimal strategy. Further and more rigorous studies are needed to better inform this decision.

From the Departments of Medicine, Mount Sinai School of Medicine, New York, NY (Dr Dunn), and McMaster University, Hamilton, Ontario (Dr Turpie). The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

The Perioperative Management of Warfarin Therapy
Jack E. Ansell
Arch Intern Med. 2003;163(8):881-883.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study
Pengo et al.
Circulation 2009;119:2920-2927.
ABSTRACT | FULL TEXT  

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
Tolosana et al.
Eur Heart J 2009;0:ehp194v2-ehp194.
ABSTRACT | FULL TEXT  

Report on a patient with pre-existing venous thrombosis and incidental malignancy undergoing urgent laparotomy: preoperative concerns
Verma and Garg
BMJ Case Reports 2009;2009:bcr1020081029-bcr1020081029.
ABSTRACT | FULL TEXT  

Permanent pacemaker implantation technique: part II
Rajappan
Heart 2009;95:334-342.
FULL TEXT  

Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
Danielyan et al.
Circulation 2008;118:1442-1449.
ABSTRACT | FULL TEXT  

Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Veitch et al.
Gut 2008;57:1322-1329.
FULL TEXT  

Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
Garcia et al.
The Annals of Pharmacotherapy 2008;42:979-988.
ABSTRACT | FULL TEXT  

Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Ansell et al.
Chest 2008;133:160S-198S.
ABSTRACT | FULL TEXT  

The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Douketis et al.
Chest 2008;133:299S-339S.
ABSTRACT | FULL TEXT  

Enoxaparin as bridging anticoagulant treatment in cardiac surgery
Rivas-Gandara et al.
Heart 2008;94:205-210.
ABSTRACT | FULL TEXT  

Perioperative Stroke
Selim
NEJM 2007;356:706-713.
FULL TEXT  

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;0:ehl428v1-39.
FULL TEXT  

Potentially Unintended Discontinuation of Long-term Medication Use After Elective Surgical Procedures
Bell et al.
Arch Intern Med 2006;166:2525-2531.
ABSTRACT | FULL TEXT  

Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction
Patatanian and Fugate
The Annals of Pharmacotherapy 2006;40:2205-2210.
ABSTRACT | FULL TEXT  

Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.
Dayani and Grand
Arch Ophthalmol 2006;124:1558-1565.
ABSTRACT | FULL TEXT  

Assessing and Reducing the Cardiac Risk of Noncardiac Surgery
Auerbach and Goldman
Circulation 2006;113:1361-1376.
FULL TEXT  

"Bridging On the River Kwai": The Perioperative Management of Anticoagulation Therapy
Eckman
Med Decis Making 2005;25:370-373.
 

Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
Dunn et al.
Med Decis Making 2005;25:387-397.
ABSTRACT  

A Feasibility Study of Continuing Dose-Reduced Warfarin for Invasive Procedures in Patients With High Thromboembolic Risk
Larson et al.
Chest 2005;127:922-927.
ABSTRACT | FULL TEXT  

Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents
Horsti et al.
Clin. Chem. 2005;51:553-560.
ABSTRACT | FULL TEXT  

Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
Kovacs et al.
Circulation 2004;110:1658-1663.
ABSTRACT | FULL TEXT  

The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT | FULL TEXT  

Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin: Assessment of a Standardized Periprocedural Anticoagulation Regimen
Douketis et al.
Arch Intern Med 2004;164:1319-1326.
ABSTRACT | FULL TEXT  

Stopping Warfarin Therapy is Unnecessary for Hand Surgery
WALLACE et al.
J Hand Surg Eur Vol 2004;29:201-203.
ABSTRACT | FULL TEXT  

Elective Hand Surgery in Patients Taking Warfarin
SMIT and HOOPER
J Hand Surg Eur Vol 2004;29:204-205.
ABSTRACT | FULL TEXT  

Costs and Clinical Outcomes Associated With Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Bridging in Patients Receiving Long-term Oral Anticoagulant Therapy
Spyropoulos et al.
Chest 2004;125:1642-1650.
ABSTRACT | FULL TEXT  

Oral Anticoagulant and Dental Procedures
Chow and Szeto
Arch Intern Med 2003;163:2532-2532.
FULL TEXT  

Perioperative Management of Patients Receiving Oral Anticoagulants
Kearon and Hirsh
Arch Intern Med 2003;163:2532-2533.
FULL TEXT  

Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy
Blacker et al.
Neurology 2003;61:964-968.
ABSTRACT | FULL TEXT  

Should Anticoagulation Be Suspended Perioperatively?
Journal Watch Cardiology 2003;2003:4-4.
FULL TEXT  

Should Anticoagulation Be Suspended Perioperatively?
JWatch General 2003;2003:5-5.
FULL TEXT  

The Perioperative Management of Warfarin Therapy
Ansell
Arch Intern Med 2003;163:881-883.
FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT